PCR monitoring for invasive aspergillosis prognosis
Part of Infections, Lungs & breathing clinical trials.
This study looks at whether repeated PCR tests for a fungus called Aspergillus fumigatus (in blood or lung fluid) can help doctors track how well treatment is working for a serious lung infection called invasive aspergillosis. It is for people who already had a positive PCR test at diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a positive Aspergillus fumigatus PCR test (blood or lung wash) at the time of diagnosis of invasive aspergillosis.
- You had at least one more PCR test more than 24 hours after the first one.
- You were diagnosed with probable or proven invasive aspergillosis (based on special medical criteria).
- You did not start antifungal treatment before the first PCR test, and you lived longer than 72 hours after starting treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to detect invasive lung aspergillosis earlier by testing samples from your lungs and measuring specific lab markers. It may help doctors start the right antifungal treatment sooner when the infection is suspected.
This study looks closely at how influenza (the flu) and a specific kind of lung fungus called Aspergillus affect people who are sick in the ICU with breathing problems. It may help doctors better understand the cause and improve treatment for severe lung infections.
This trial looks at CT scan results to see if they can help predict how someone with a serious lung infection caused by Mucorales fungus will do. It asks whether certain features on CT scans can give clues about recovery and future health.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
This study looks at Aspergillus fungus samples from people’s lungs to understand why some become resistant to a key treatment (azole medicines). If you’ve had a sample showing Aspergillus in the past few years and live in certain areas of France, you may be able to help.
This study looks at how the presence of fungus in lung samples relates to the long-term outlook for people with allergic bronchopulmonary aspergillosis (ABPA). It aims to help doctors better understand the disease and guide treatment.
Hear when a new Invasive Pulmonary Aspergillosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.